Frontlight ResearchEarly access
Childhood cancers trials in United States
932 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3WithdrawnStudy of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
- Where
- Atlanta, Augusta, Birmingham, Charlottesville, Cleveland, Columbus, Dallas, Eugene, Fairfax, Fort Worth, Houston, Indianapolis, La Jolla, Little Rock, Melrose Park, New Orleans, New York, Philadelphia, Phoenix, Providence, Richmond, Savannah, Shreveport, Syracuse, Tucson, Tyler, West Hollywood
- Age
- 15 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00 - No phaseTaking peoplePatient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Where
- Aurora, Boston, Hackensack, Memphis, New York, Palo Alto, Rochester
- Age
- 8 years and over
- People
- 100
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06098430 - Phase 2Taking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Chicago, Cincinnati, New Brunswick, New York, Seattle
- Age
- 1 year to 18 years
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - Phase 2Taking peopleA Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
- Where
- Iowa City
- Age
- 12 years to 17 years
- People
- 15 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07700758 · EU 2025-524515-37-00 - Phase 1Taking peopleBlood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)
- Where
- Washington D.C.
- Age
- 3 years to 25 years
- People
- 45
- Run by
- Children's National Research Institute
See details and how to joinNCT07796061 - No phaseTaking peopleStigma Healing Inventory Evaluation
- Where
- Memphis
- Age
- 8 years and over
- People
- 2,980
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07882927 - No phaseTaking peopleOptimal Defaults Grocery Shopping Intervention to Promote Healthy Diets for Pediatric Cancer Survivors and Their Families
- Where
- Buffalo
- Age
- 2 years and over
- People
- 160
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT07901816 - No phaseTaking peopleStudies on Tumors of the Thyroid
- Where
- Bethesda
- Age
- 6 months to 98 years
- People
- 2,500
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT00001160 - No phaseTaking peoplePsychological Benefits of a Normalized Camping Experience for Children With Cancer
- Where
- Bethesda
- Age
- 7 years to 25 years
- People
- 5,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00001186 - No phaseTaking peopleCollection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
- Where
- Bethesda
- Age
- 2 years and over
- People
- 5,950
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00026884 - No phaseEnrolling by invitationFollow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
- Where
- Bethesda
- Age
- 1 year to 99 years
- People
- 500
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02315599 - No phaseEnrolling by invitationLeukapheresis for CAR or Adoptive Cell Therapy Manufacturing
- Where
- Bethesda
- Age
- 3 years to 65 years
- People
- 120
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03226704 - No phaseTaking peopleBiospecimen Procurement for Head and Neck Disorders
- Where
- Baltimore, Bethesda, Washington D.C.
- Age
- 3 years to 120 years
- People
- 1,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03429036 - No phaseTaking peopleNatural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
- Where
- Bethesda, Houston, Portland
- Age
- 4 weeks and over
- People
- 10,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03739827 - No phaseTaking peopleChildren and Adults With Chordoma
- Where
- Bethesda
- Age
- 2 years and over
- People
- 300
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03910465 - Phase 1CompletedA Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- Where
- Atlanta, Beverly Hills, Denver, Houston
- Age
- 12 years and over
- People
- 276 worldwide
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT04192344 - Phase 1Taking peopleMetarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Where
- Bethesda, Fairway
- Age
- 12 years to 120 years
- People
- 116
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04222413 - No phaseTaking peopleSurgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
- Where
- Bethesda
- Age
- 6 years and over
- People
- 400
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04557969 - Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Ann Arbor, Cincinnati, Dallas, Houston, Milwaukee, New York, Portland, Salt Lake City, St Louis
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 1/2Taking peoplePhase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
- Where
- Bethesda, Philadelphia
- Age
- 12 years to 85 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04959175 - No phaseTaking peopleCognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
- Where
- Bethesda, Los Angeles, Seattle
- Age
- 5 years and over
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05237986 - Phase 1/2Taking peopleDonor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- Where
- Bethesda
- Age
- 12 years to 120 years
- People
- 430
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05327023 - Phase 1/2Taking peopleTrial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- Where
- Bethesda
- Age
- 12 years to 120 years
- People
- 265
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05470491 - Phase 2Taking peopleA Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- People
- 100
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06057948 - Phase 2Taking peopleTarget Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
- Where
- Ann Arbor, Baltimore, Birmingham, Durham, Hackensack, Indianapolis, Memphis, Salt Lake City, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 1 year to 39 years
- People
- 30 worldwide
- Run by
- University of California, San Francisco
See details and how to joinNCT07226453